CD79A and lymphoma: Rocha et al. (2016) found that supplementation with Se reduced neutropenic cases (leukemia/lymphomas (LL) and solid tumors (ST) in patients), reduced IgG and IgA levels in LL, and increased IgG and IgA levels in the ST group [9].